(Q52242595)
Statements
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. (English)
1 reference
Nemunaitis J
1 reference
Poole C
1 reference
Primrose J
1 reference
Rosemurgy A
1 reference
Malfetano J
1 reference
Brown P
1 reference
Berrington A
1 reference
Cornish A
1 reference
Lynch K
1 reference
Rasmussen H
1 reference
Kerr D
1 reference
Cox D
1 reference
Millar A
1 reference
1 May 1998
1 reference
4
1 reference
5
1 reference
1101-1109
1 reference